The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Early-onset, familial Alzheimer's disease (AD) is rare and may be attributed to disease-causinq mutations. By contrast, late onset, sporadic (non-Mendelian) AD is far more prevalent and reflects the interaction of multiple genetic and environmental risk factors, together with the disruption of epigenetic mechanisms controlling gene expression. Accordingly, abnormal patterns of histone acetylation and methylation, as well as anomalies in global and promoter-specific DNA methylation, have been documented in AD patients, together with a deregulation of noncoding RNA. In transgenic mouse models for AD, epigenetic dysfunction is likewise apparent in cerebral tissue, and it has been directly linked to cognitive and behavioral deficits in functional studies. Importantly, epigenetic deregulation interfaces with core pathophysiological processes underlying AD: excess production of Aβ42, aberrant post-translational modification of tau, deficient neurotoxic protein clearance, axonal-synaptic dysfunction, mitochondrial-dependent apoptosis, and cell cycle re-entry. Reciprocally, DNA methylation, histone marks and the levels of diverse species of microRNA are modulated by Aβ42, oxidative stress and neuroinflammation. In conclusion, epigenetic mechanisms are broadly deregulated in AD mainly upstream, but also downstream, of key pathophysiological processes. While some epigenetic shifts oppose the evolution of AD, most appear to drive its progression. Epigenetic changes are of irrefutable importance for AD, but they await further elucidation from the perspectives of pathogenesis, biomarkers and potential treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962
A brain-specific microRNA regulates dendritic spine development
Schratt, G. M., Tuebing, F., Nigh, E. A., Kane, C. G., Sabatini, M. E., Kiebler, M., & Greenberg, M. E. (2006) · Nature · doi:10.1038/nature04367 · Cited by 1,786
Recovery of learning and memory is associated with chromatin remodelling
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227
Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., & De Strooper, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710263105 · Cited by 1,183
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039
A novel pathway regulates memory and plasticity via SIRT1 and miR-134
Gao, J., Wang, W.-Y., Mao, Y.-W., Gräff, J., Guan, J.-S., Pan, L., Mak, G., Kim, D., Su, S. C., & Tsai, L.-H. (2010) · Nature · doi:10.1038/nature09271 · Cited by 975
Research works printed but not linked: 139
- Reitz C., 2011, Nat Rev Neurol., 7, 137, 10.1038/nrneurol.2011.2 · DOI · Paper page
- Adwan L., 2013, Pharmacol Ther., 139, 41, 10.1016/j.pharmthera.2013.03.010 · DOI · Paper page
- Anand R., 2014, Neuropharmacology., 76, 27, 10.1016/j.neuropharm.2013.07.004 · DOI · Paper page
- Jacobs HI., 2013, Neurosci Biobehav Rev., 37, 753, 10.1016/j.neubiorev.2013.03.009 · DOI
- Martin L., 2011, Neurochem Int., 58, 458, 10.1016/j.neuint.2010.12.023 · DOI · Paper page
- Khandelwal PJ., 2011, J Neuroimmunol., 238, 1, 10.1016/j.jneuroim.2011.07.002 · DOI · Paper page
- Mukhopadhyay S., 2014, Apoptosis., 19, 555, 10.1007/s10495-014-0967-2 · DOI · Paper page
- Swiss VA., 2010, Glia., 58, 377, 10.1002/glia.20933 · DOI
- Huang Y., 2010, Mol Med., 16, 287, 10.2119/molmed.2009.00165 · DOI
- Lambert JC., 2011, Genet Dev., 21, 295, 10.1016/j.gde.2011.02.002 · DOI
- Lu H., 2013, Front Aging Neurosci., 5, 85
- Mastroeni D., 2011, Neurobiol Aging., 32, 1161, 10.1016/j.neurobiolaging.2010.08.017 · DOI · Paper page
- Wang J., 2013, Ageing Res Rev., 12, 1024, 10.1016/j.arr.2013.05.003 · DOI
- Bihaqi SW., 2012, Curr Alzheimer Res., 9, 574, 10.2174/156720512800617982 · DOI · Paper page
- Bradley-Whitman MA., 2013, Mech Ageing Dev., 134, 486, 10.1016/j.mad.2013.08.005 · DOI · Paper page
- Cencioni C., 2013, Int J Mol Sci., 14, 17643, 10.3390/ijms140917643 · DOI · Paper page
- Walker MP., 2013, Age (Disorder)., 35, 519, 10.1007/s11357-011-9375-5 · DOI
- Deaton AM., 2011, Genes Dev., 25, 1010, 10.1101/gad.2037511 · DOI · Paper page
- Grayson DR., 2013, Neuropsychopharmacology., 38, 138, 10.1038/npp.2012.125 · DOI · Paper page
- Fleming JL., 2012, Curr Alzheimer Res., 9, 1077, 10.2174/156720512803569000 · DOI
- Chouliaras L., 2013, Neurobiol Aging., 34, 2091, 10.1016/j.neurobiolaging.2013.02.021 · DOI · Paper page
- Coppieters N., 2014, Neurobiol Aging., 35, 1334, 10.1016/j.neurobiolaging.2013.11.031 · DOI · Paper page
- Iwata A., 2014, Hum Mol Genet., 23, 648, 10.1093/hmg/ddt451 · DOI · Paper page
- Fuso A., 2012, Curr Alzheimer Res., 9, 527, 10.2174/156720512800618053 · DOI
- Fuso A., 2005, Mol Cell Neurosci., 28, 195, 10.1016/j.mcn.2004.09.007 · DOI · Paper page
- Guo X., 2011, Neurocience., 194, 272, 10.1016/j.neuroscience.2011.07.012 · DOI
- Rao JS., 2012, Transl Psychiatry., 2, e132, 10.1038/tp.2012.55 · DOI · Paper page
- Gu X., 2013, Neurobiol Aging., 34, 1069, 10.1016/j.neurobiolaging.2012.10.013 · DOI
- Chen KL., 2009, Biochem Biophys Res Commun., 378, 57, 10.1016/j.bbrc.2008.10.173 · DOI
- Taher N., 2014, J Alzheimers Dis., 38, 831, 10.3233/JAD-131061 · DOI
- Van den Hove DL., 2014, Neurobiol Aging., 35, 731, 10.1016/j.neurobiolaging.2013.10.082 · DOI
- Xu B., 2012, Neurobiol Dis., 46, 291, 10.1016/j.nbd.2012.02.016 · DOI · Paper page
- Sun G., 2011, Nat Commun., 2, 529, 10.1038/ncomms1532 · DOI · Paper page
- Li X., 2013, Neurobiol Learn Mem., 105, 125, 10.1016/j.nlm.2013.06.009 · DOI
- Kouzarides T., 2007, Cell., 128, 693, 10.1016/j.cell.2007.02.005 · DOI · Paper page
- Day JJ., 2011, Neuron., 70, 813, 10.1016/j.neuron.2011.05.019 · DOI · Paper page
- Jarome TJ., 2013, Rev Neurosci., 24, 375, 10.1515/revneuro-2013-0008 · DOI · Paper page
- Zhang K., 2012, Proteomics., 12, 1261, 10.1002/pmic.201200010 · DOI · Paper page
- Francis Yl., 2009, J Alzheimers Dis., 18, 131, 10.3233/JAD-2009-1134 · DOI · Paper page
- Zhang ZY., 2013, J Neuropathol Exp Neurol., 72, 178, 10.1097/NEN.0b013e318283114a · DOI · Paper page
- Bie B., 2014, Nat Neurosci., 17, 223, 10.1038/nn.3618 · DOI
- Lithner CU., 2013, Neurobiol Aging., 34, 2081, 10.1016/j.neurobiolaging.2012.12.028 · DOI
- Wang Z., PLoS One., 6, e19229, 10.1371/journal.pone.0019229 · DOI · Paper page
- Barry G., 2014, Mol Psychiatry., 19, 410, 10.1038/mp.2013.196 · DOI
- Bartel, 2009, Cell., 136, 215, 10.1016/j.cell.2009.01.002 · DOI · Paper page
- Bernstein BE., 2012, Nature., 489, 57, 10.1038/nature11247 · DOI · Paper page
- Qureshi IA., 2013, Neurotherapeutics., 10, 632, 10.1007/s13311-013-0199-0 · DOI
- Millan MJ., 2011, Curr Opin Pharmacol., 11, 11, 10.1016/j.coph.2011.01.008 · DOI
- Goodall EF., 2013, Front Cell Neurosci., 7, 178, 10.3389/fncel.2013.00178 · DOI · Paper page
- Lau P., 2014, Ageing Res Rev., 17G43
- Satoh J., 2012, Exp Neurol., 235, 436, 10.1016/j.expneurol.2011.09.003 · DOI
- Long JM., 2012, Exp Neurol., 235, 402, 10.1016/j.expneurol.2011.12.043 · DOI · Paper page
- Lukiw WJ., 2007, Neuroreport., 18, 297, 10.1097/WNR.0b013e3280148e8b · DOI · Paper page
- Müller M., 2014, Neurobiol Aging., 35, 152, 10.1016/j.neurobiolaging.2013.07.005 · DOI · Paper page
- Chai S., 2013, Proc Natl Acad Sci U S A., 110, 17898, 10.1073/pnas.1317528110 · DOI
- Lau P., 2013, EMBO Mol Med., 5, 1613, 10.1002/emmm.201201974 · DOI · Paper page
- Smith PY., 2011, Hum Mol Genet., 20, 4016, 10.1093/hmg/ddr330 · DOI · Paper page
- Smith P., 2011, J Neurochem., 116, 240, 10.1111/j.1471-4159.2010.07097.x · DOI · Paper page
- Wang WX., 2008, J Neurosci., 28, 1213, 10.1523/JNEUROSCI.5065-07.2008 · DOI · Paper page
- Schonrock N., 2012, J Mol Neurosci., 46, 324, 10.1007/s12031-011-9587-2 · DOI · Paper page
- Nunez-lglesias J., 2010, PLoS One., 5, e8898, 10.1371/journal.pone.0008898 · DOI · Paper page
- Persengiev S., 2011, Neurobiol Aging., 32, 2316e17, 10.1016/j.neurobiolaging.2010.03.014 · DOI
- Shioya M., 2010, Neuropathol Appl Neurobioi., 36, 320, 10.1111/j.1365-2990.2010.01076.x · DOI · Paper page
- Geekiyanage H., 2012, Exp Neurol., 235, 491, 10.1016/j.expneurol.2011.11.026 · DOI · Paper page
- Braidy N., 2012, Curr Opin Psychiatry., 25, 226, 10.1097/YCO.0b013e32835112c1 · DOI · Paper page
- Min SW., 2013, Front Aging Neurosci., 5, 1
- Moon JM., 2013, J Cereb Blood Flow Metab., 33, 1976, 10.1038/jcbfm.2013.157 · DOI · Paper page
- Ouyang YB., 2012, Mitochondrion., 12, 213, 10.1016/j.mito.2011.09.001 · DOI · Paper page
- Zhang L., 2012, J Neuroinflammation., 9, 211, 10.1186/1742-2094-9-211 · DOI · Paper page
- Barak B., 2013, Transl Psychiatry., 3, e304, 10.1038/tp.2013.77 · DOI · Paper page
- Delay C., 2011, Int J Alzheimer's Disease., 894938
- Boissoneault V., 2009, J Biol Chem., 284, 1971, 10.1074/jbc.M807530200 · DOI · Paper page
- Liu W., 2012, Neurobiol Aging., 33, 522, 10.1016/j.neurobiolaging.2010.04.034 · DOI · Paper page
- Zhang R., 2014, mice. J Neurol Sci., 338, 57, 10.1016/j.jns.2013.12.017 · DOI
- Caraci F., 2012, Cell Tissue Res., 347, 291, 10.1007/s00441-011-1230-6 · DOI
- Li JJ., 2014, PLoS One., 9, e90770, 10.1371/journal.pone.0090770 · DOI
- Xu S., 2012, Int J Mol Sci., 13, 16945, 10.3390/ijms131216945 · DOI · Paper page
- Chio CC., 2013, Arch Toxicol., 87, 459, 10.1007/s00204-012-0965-5 · DOI
- Lukiw WJ., 2013, Front Genet., 3, 327, 10.3389/fgene.2012.00327 · DOI · Paper page
- Wang LL., 2012, Med Hypotheses., 78, 398, 10.1016/j.mehy.2011.11.019 · DOI
- Boldin MP., 2012, Immunol Rev., 246, 205, 10.1111/j.1600-065X.2011.01089.x · DOI · Paper page
- Lukiw WJ., 2012, Mol Neurobiol., 46, 11, 10.1007/s12035-012-8234-4 · DOI · Paper page
- Zhao Y., Mol Neurobiol. In press.
- Toh H., 2011, J Mol Neurosci., 45, 538, 10.1007/s12031-011-9569-4 · DOI
- Wang WX., 2010, Am J Pathol., 177, 334, 10.2353/ajpath.2010.091202 · DOI · Paper page
- Lukiw WJ., 2012, Neuroreport., 23, 621
- Lehmann SM., 2012, Nat Neurosci., 15, 827, 10.1038/nn.3113 · DOI · Paper page
- Hébert SS., 2009, Neurobiol Disease., 33, 422, 10.1016/j.nbd.2008.11.009 · DOI · Paper page
- Patel N., 2008, Mol Neurodegen., 3, 10, 10.1186/1750-1326-3-10 · DOI · Paper page
- Roshan R., 2012, RNA Biol., 9, 891, 10.4161/rna.19876 · DOI
- Faghihi MA., 2010, Genome Biol., 11, R56, 10.1186/gb-2010-11-5-r56 · DOI · Paper page
- Fang M., 2012, Toxicol Lett., 209, 94, 10.1016/j.toxlet.2011.11.032 · DOI · Paper page
- Zhang C., 2010, J Biol Chem., 285, 8515, 10.1074/jbc.M109.079079 · DOI · Paper page
- Augustin R., 2012, BMC Med Genet., 13, 35, 10.1186/1471-2350-13-35 · DOI · Paper page
- Cheng C., 2013, J Biol Chem., 288, 13748, 10.1074/jbc.M112.381392 · DOI · Paper page
- Xu D., 2009, FASEB J., 23, 3674, 10.1096/fj.09-133462 · DOI · Paper page
- Lukiw WJ., 2012, Exp Neurol., 235, 484, 10.1016/j.expneurol.2011.11.022 · DOI · Paper page
- Dickson JR., 2013, J Neurochem., 127, 739, 10.1111/jnc.12437 · DOI · Paper page
- Hebert SS., 2010, Hum Mol Genet., 19, 3959, 10.1093/hmg/ddq311 · DOI · Paper page
- Aranha MM., 2011, PLoS One., 6, e21396, 10.1371/journal.pone.0021396 · DOI · Paper page
- Im HI., 2012, Trends Neurosci., 35, 325, 10.1016/j.tins.2012.01.004 · DOI · Paper page
- Yamakuchi M., 2008, Proc Natl Acad Sci U S A., 105, 13421, 10.1073/pnas.0801613105 · DOI · Paper page
- Dajas-Bailador F., 2012, Nat Neurosci., 15, 697, 10.1038/nn.3082 · DOI · Paper page
- Haramati S., 2010, Proc Natl Acad Sci U S A., 107, 13111, 10.1073/pnas.1006151107 · DOI · Paper page
- Cohen JE., 2011, Proc Natl Acad Sci U S A., 108, 11650, 10.1073/pnas.1017576108 · DOI · Paper page
- Ouyang YB., 2014, Neurosci Lett., 565, 53, 10.1016/j.neulet.2013.11.015 · DOI · Paper page
- Wei C., 2013, PLoS One., 8, e57080, 10.1371/journal.pone.0057080 · DOI
- Muddashetty RS., 2011, Mol Cell., 42, 673, 10.1016/j.molcel.2011.05.006 · DOI · Paper page
- Wibrand K., 2012, PLoS One., 7, e41688, 10.1371/journal.pone.0041688 · DOI · Paper page
- Follert P., 2014, Front Mol Neurosci., 7, 5, 10.3389/fnmol.2014.00005 · DOI · Paper page
- Garza-Manero S., 2014, Brain Res. In press.
- Yao J., 2010, PLoS One., 5, e15546, 10.1371/journal.pone.0015546 · DOI · Paper page
- Ji G., 2013, PLoS One., 8, e69351, 10.1371/journal.pone.0069351 · DOI
- He M., 2014, Cell Death Dis., 5, e1090, 10.1038/cddis.2014.60 · DOI
- Isaya G., 2014, Front Pharmacol., 5, 29, 10.3389/fphar.2014.00029 · DOI · Paper page
- Akhter R., 2014, J Biol Chem., 289, 10812, 10.1074/jbc.M113.519355 · DOI · Paper page
- Wong HK., 2013, Hum Mol Genet., 22, 3077, 10.1093/hmg/ddt164 · DOI · Paper page
- Kole AJ., 2011, Genes Development., 25, 125, 10.1101/gad.1975411 · DOI · Paper page
- Truettner JS., 2013, Brain Res., 1533, 122, 10.1016/j.brainres.2013.08.011 · DOI · Paper page
- Bonda DJ., 2001, J Alzheimers Dis., 3, 377, 10.3233/JAD-2001-3403 · DOI · Paper page
- Seward ME., 2013, J Cell Sci., 126, 1278, 10.1242/jcs.1125880 · DOI · Paper page
- Ranganathan S., 2001, J Alzheimers Dis., 3, 377, 10.3233/JAD-2001-3403 · DOI · Paper page
- Riba A., 2014, PLoS Comput Biol., 27, e1003490, 10.1371/journal.pcbi.1003490 · DOI
- Trompeter HI., 2011, PLoS One., 6, e16138, 10.1371/journal.pone.0016138 · DOI · Paper page
- Ueberham U., 2012, Neurobiol Aging., 33, 2827, 10.1016/j.neurobiolaging.2012.01.013 · DOI
- Wang H., 2010, Brain Res., 1357, 166, 10.1016/j.brainres.2010.08.023 · DOI
- Füllgrabe J., 2014, Nat Rev Mol Cell Biol., 15, 65, 10.1038/nrm3716 · DOI · Paper page
- Lee MJ., 2013, Prog Neurobiol., 105, 49, 10.1016/j.pneurobio.2013.03.001 · DOI · Paper page
- Fenn AM., 2013, Neurobiol Aging., 34, 2748, 10.1016/j.neurobiolaging.2013.06.007 · DOI · Paper page
- Salminen A., 2013, Prog Neurobiol., 106, 33, 10.1016/j.pneurobio.2013.06.002 · DOI · Paper page
- Carrettiero DC., 2009, J Neurosci., 29, 2151, 10.1523/JNEUROSCI.4660-08.2009 · DOI · Paper page
- Massone S., 2011, Neurobiol Dis., 41, 308, 10.1016/j.nbd.2010.09.019 · DOI · Paper page
- Lukiw WJ., 2013, Front Genet., 4, 307
- Landry CD., 2013, Trends Neurosci., 36, 535, 10.1016/j.tins.2013.05.004 · DOI
- Mus E., 2007, Proc Natl Acad Sci U S A., 104, 10679, 10.1073/pnas.0701532104 · DOI · Paper page
- Salta E., 2012, Lancet Neurol., 11, 189, 10.1016/S1474-4422(11)70286-1 · DOI · Paper page
- Dorval V., 2013, Front Mol Neurosci., 6, 24
- Sheinerman KS., 2013, Front Cell Neurosci., 7, 150, 10.3389/fncel.2013.00150 · DOI · Paper page
- Wahlestedt C., 2013, Nat Rev Drug Discov., 12, 433, 10.1038/nrd4018 · DOI · Paper page
Cited by
Homocysteine, B Vitamins, and Cognitive Impairment
Smith, A. D., & Refsum, H. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050947 · Cited by 513
Monoaminergic neuropathology in Alzheimer’s disease
Šimić, G., Babić Leko, M., Wray, S., Harrington, C. R., Delalle, I., Jovanov-Milošević, N., Bažadona, D., Buée, L., de Silva, R., Di Giovanni, G., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.001 · Cited by 289
Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease
Zheng, Y., Liu, A., Wang, Z.-J., Cao, Q., Wang, W., Lin, L., Ma, K., Zhang, F., Wei, J., Matas, E., et al. (2019) · Brain · doi:10.1093/brain/awy354 · Cited by 168
Schiele, M. A., Gottschalk, M. G., & Domschke, K. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101830 · Cited by 156
Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132
Self-citation
Metadata
- Authors
- Millan, M. J.
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2014-09-30
- Volume
- 16
- Issue
- 3
- Pages
- 373-393
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- OpenAlex
- W2156676300
- Cited by
- 63
- References
- 48
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity? https://app.cochat.ai/papers/10.31887/dcns.2014.16.3/mmillan
- The paper
- Millan, M. J. (2014). The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity? Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2014.16.3/mmillan
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.